The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

TOKYO -- About 90% of patients with "obesity disease" in Japan perceive the medical condition as a personal responsibility, ...

A higher BMI is consistently associated with longer operative times and increased complications across a wide range of ...

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...

Pancreatic cancer, one of the deadliest types of the disease, has been linked to obesity and higher stress levels, a new UCLA ...

Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.

Cervical disc replacement is a safe option across all obesity levels compared to anterior cervical discectomy and fusion, ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...

Adding an anti-obesity medication just one month after behavioral therapy begins-rather than waiting the currently recommended six months-can more than double weight loss for patients who struggle ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

FibroScan overestimated advanced fibrosis and cirrhosis in patients with class 3 obesity and metabolic dysfunction-associated steatotic liver disease.